Use your browser's back button to choose another title or click here for a New Search.

How to Get the Poster

 Open slide (ppt)


Bookmark and Share

Hepatitis C Virus Services Offered by Substance Abuse Treatment Programs in the U.S.

Poster presented at the "Hepatitis C: Breaking the Silence on the Epidemic" conference at the New York Academy of Medicine, March 2007.

Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, NY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, NY Node), Lawrence S. Brown Jr., MD, MPH (Addiction Research and Treatment Corporation, NY Node), James A. Robinson, MEd (Nathan Kline Institute for Psychiatric Research, NY/LI Node), Donald Alderson, MS (New York State Psychiatric Institute, NY Node), Patrick McAuliffe, MBA, LADC (Connecticut Renaissance, Inc., NE Node), Carrie Smith, BA, CACP (Behavioral Health Services of Pickens County, SC Node), John Rotrosen, MD (New York University, NY Node), CTN Infections Study Team (CTN-0012).

This poster describes the rationale, objectives, procedures, and outcomes of one facet of protocol CTN-0012 ("Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs"). The protocol examined the associations between HIV/AIDS, hepatitis C (HCV), and sexually transmitted infection (STI)-related services provided by substance abuse treatment programs in the National Institute on Drug Abuse Clinical Trials Network (NIDA CTN), and the states within which they are located.

The poster focuses specifically on the availability of Hepatitis C virus services (including medical history/physical exam; biological testing; patient treatment, monitoring, and education; provider education; patient risk assessment; and patient counseling) offered by substance abuse treatment programs, as well as the determination of whether HCV-related health services differ between programs that do and do not have clear guidelines for hepatitis testing, and methadone and non-methadone programs. The study used a cross-sectional survey sent to 319 treatment program administrators in the CTN; 269 administrators (84.3%) replied to the survey, representing a geographically diverse location from across the US. Despite the importance of substance abuse in sustaining the HCV epidemic in the U.S., the data shows that many substance abuse treatment programs do not offer comprehensive HCV-related services. Public health interventions to improve access to hepatitis testing, treatment, and prevention for substance abusers are needed. (Poster, PowerPoint slides, English, 2007)

Keywords: Community health services | Health services research | Hepatitis C | Sexually transmitted diseases

Document No: 200

Submitted by Steven Kritz, M.D., New York Node (6/11/2007).

Alderson, Donald search
Bini, Edmund J. search mail
Brown, Lawrence S. Jr. search mail
Kritz, Steven Allan search mail
McAuliffe, Patrick search mail
Robinson, James A. search mail
Rotrosen, John search mail
Smith, Carrie search mail
NIDA-CTN-0012 search www
All Nodes and CTPs were asked to participate in this study

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2009 --